Header Logo

Connection

Dhriti Sengupta to Piperazines

Back to Details
This is a "connection" page, showing publications Dhriti Sengupta has written about Piperazines.
Dhriti Sengupta
Connection Strength
0,047
Piperazines
  1. UGT1A1 regulatory variant with potential effect on efficacy of HIV and cancer drugs commonly prescribed in South Africa. Pharmacogenomics. 2021 10; 22(15):963-972.
    View in: PubMed
    Score: 0,047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.